2016-11-15T14:55:22-06:00 2015-12-31 BDO USA LLP 32125 SOLON ROAD SOLON OH 44139 990 2015-01-01 270486705 ALLIANCE FOR REGENERATIVE MEDICINE % THOMAS J DULA ALLI 2024192515 525 SECOND STREET NE WASHINGTON DC 20002 EDWARD LANPHIER CHAIRMAN 2024192515 2016-11-02 true MELANIE WERNERT P01258969 4402488787 2015 2017-02-10 21:41:12Z EDWARD LANPHIER 525 SECOND STREET NE WASHINGTON DC 20002 2976141 false X WWW.ALLIANCERM.ORG X 2009 DC SEE SCHEDULE O 38 38 0 275 0 27203 0 2359193 2976080 39 61 0 0 2386435 2976141 0 0 0 0 0 0 0 0 0 2358077 2771703 2358077 2771703 28358 204438 801815 1143330 139034 855644 662781 287686 X THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. false false 1265790 2157514 COMMUNICATIONS, CAPITAL FORMATION, AND OPERATIONS: TO DEVELOP PUBLICATIONS, SOCIAL MEDIA STRATEGIES, AND OTHER MATERIALS THAT WILL EDUCATE THE PUBLIC ABOUT REGENERATIVE MEDICINE. 877648 818566 POLICY, ADVOCACY, AND GOVERNMENT RELATIONS: TO PROVIDE MEETINGS AND WORKSHOPS THAT WILL ASSIST MEMBERS WITH GOVERNMENT RELATIONS AND REGULATORY DECISION MAKING. 201936 SCIENCE AND TECHNOLOGY: TO DEVELOP CONSENSUS PRODUCT DEVELOPMENT AND REGULATORY STANDARDS, AND PROVIDE MORE EFFICIENT ACCESS TO INDUSTRY BEST-PRACTICES REGARDING MANUFACTURING AND SCALE-UP. 2345374 false false false true false false false false false true false false false true true true false false false false false false false false false false false false false false false false false false false false true false false false false false false false false true 14 0 0 false false false false true true false X 38 38 false true false false false true false true true false false false true true true false false false false false DC X THOMAS J DULA 7038551301 525 SECOND STREET NE WASHINGTON DC 20002 CLAUDIA ZYLBERBERG TREASURER 1.35 0.0 X X 0 0 0 PHIL VANEK SECRETARY 1.15 0.0 X X 0 0 0 BOB PRETI VICE CHAIRMAN 1.35 0.0 X X 0 0 0 EDWARD LANPHIER CHAIRMAN 1.54 0.0 X X 0 0 0 DOUG DOERFLER DIRECTOR 0.77 0.0 X 0 0 0 EDUARDO BRAVO DIRECTOR 0.29 0.0 X 0 0 0 FLAGG FLANAGAN DIRECTOR 0.29 0.0 X 0 0 0 CHRISTIAN HOMSY DIRECTOR 0.29 0.0 X 0 0 0 PERRY KARSEN DIRECTOR 0.19 0.0 X 0 0 0 DOUG KERR DIRECTOR 0.12 0.0 X 0 0 0 DENA LADD DIRECTOR 0.23 0.0 X 0 0 0 MARTIN ANDREWS DIRECTOR 0.12 0.0 X 0 0 0 GEOFF MACKAY DIRECTOR EX-OFFICIO 0.23 0.0 X 0 0 0 MICHAEL MAY DIRECTOR 0.29 0.0 X 0 0 0 MARTIN MCGLYNN DIRECTOR 0.12 0.0 X 0 0 0 RANDY MILLS DIRECTOR 0.23 0.0 X 0 0 0 KIETH MURPHY DIRECTOR 0.12 0.0 X 0 0 0 MATT PATTERSON DIRECTOR 0.12 0.0 X 0 0 0 STEVE PAUL DIRECTOR 0.04 0.0 X 0 0 0 RAHUL ARAS DIRECTOR 0.29 0.0 X 0 0 0 ISABELLE RIVIERE DIRECTOR 0.19 0.0 X 0 0 0 MARTHA ROOK DIRECTOR 0.29 0.0 X 0 0 0 BERNIE SEIGEL DIRECTOR 0.12 0.0 X 0 0 0 JAY SIEGEL DIRECTOR 0.77 0.0 X 0 0 0 MATTHIEU SIMON DIRECTOR 0.04 0.0 X 0 0 0 DAVID SMITH DIRECTOR 0.29 0.0 X 0 0 0 DEVYN SMITH DIRECTOR 0.48 0.0 X 0 0 0 SUSAN SOLOMON DIRECTOR 0.12 0.0 X 0 0 0 DORIS TAYLOR DIRECTOR 0.04 0.0 X 0 0 0 KEITH THOMPSON DIRECTOR 0.23 0.0 X 0 0 0 GIL VAN BOKKELER DIRECTOR 0.58 0.0 X 0 0 0 USMAN AZAM DIRECTOR 0.29 0.0 X 0 0 0 ALEXANDER VOS DIRECTOR 0.29 0.0 X 0 0 0 JEFF WALSH DIRECTOR 0.12 0.0 X 0 0 0 SUSAN WASHER DIRECTOR 0.19 0.0 X 0 0 0 ZAMI ABERMAN DIRECTOR 0.12 0.0 X 0 0 0 DONNA SKERRETT DIRECTOR 0.23 0.0 X 0 0 0 LUCIE BRUJIN DIRECTOR 0.04 0.0 X 0 0 0 THOMAS J DULA CHIEF FINANCIAL OFFICER 6.0 0.0 X 38400 0 0 38400 0 0 0 false false false ADJUVANT PARTNERS LLC 722 DULANEY VALLEY ROAD SUITE 262 TOWSON MD 21204 STAFFING SERVICES 360000 HOLLAND KNIGHT LLP 800 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 STAFFING SERVICES 360000 2 0 MEMBERSHIP DUES 1539227 1539227 STEM CELL CONFERENCE 926797 926797 MEMBERSHIP MEETINGS 271507 271507 REGENMED INVESTOR MEETING 238549 238549 2976080 61 61 0 0 0 0 0 0 0 0 0 0 2976141 2976080 61 0 0 0 0 0 0 0 0 0 0 360000 270000 90000 0 91448 90966 482 0 49625 0 49625 0 877648 877648 0 0 0 0 149528 112285 37243 0 0 14328 0 14328 0 16719 7290 9429 0 0 36500 0 36500 0 25595 20129 5466 0 0 649038 649038 0 0 0 0 115 0 115 0 10500 10500 0 0 STRATEGIC PRIORITY 141951 107726 34225 0 MEMBERSHIP SUPPORT 102209 78622 23587 0 EUROPEAN UNION SECTION 65874 57820 8054 0 BAD DEBT EXPENSE 87000 0 87000 0 93625 63350 30275 2771703 2345374 426329 0 141494 266967 167134 267177 0 0 493187 602700 0 0 0 0 0 0 0 0 0 5227 1374 115 0 1259 0 0 0 0 0 0 0 0 0 0 801815 1143330 139034 70249 0 0 0 783552 0 0 0 0 0 0 0 0 0 0 0 1843 139034 855644 X 662781 287686 0 0 0 0 662781 287686 801815 1143330 204438 -579533 X false true X true false false false false 1539227 877648 126956 1004604 877648 126956 0 1374 115 1259 1259 0 RELATED PARTY PAYABLE 1843 1843 X 2976141 2976141 2976141 2771703 2771703 2771703 PART X, LINE 2: THE ALLIANCE IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE. INCOME TAXES ON UNRELATED BUSINESS INCOME, IF ANY, ARE PROVIDED AT THE APPLICABLE RATES ON INCOME FOR FINANCIAL REPORTING PURPOSES. THE ALLIANCE HAS ADOPED THE ACCOUNTING GUIDANCE FOR UNCERTAINTY IN INCOME TAXES. USING THAT GUIDANCE, TAX POSITIONS INITIALLY NEED TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE-LIKELY-THAN-NOT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAX AUTHORITIES. AS THE DECEMBER 31, 2015, THE ALLIANCE HAD NO UNCERTAIN TAX POSTIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE ALLIANCE'S INCOME TAX FILINGS ARE SUBJECT TO AUDIT BY VARIOUS TAXING AUTHORITIES. IN EVALUATING ITS ACTIVITIES, THE ALLIANCE BELIEVES ITS POSTION ON TAX-EXEMPT STATE IS CURRENT BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE ALLIANCE HAS ASSESSED THAT THERE ARE NO ACTIVTIES UNRELATED TO ITS PURPOSE AND, THEREFORE, NO TAX IS TO BE RECOGNIZED. IT IS THE POLICY OF THE ALLIANCE TO INCLUDE IN EXPENSES, PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES. THERE ARE NO PENALITES OR INTEREST FROM TAXING AUTHORITIES INCLUDED IN EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2015. 0 ADJUVANT PARTNERS LLC FORMER DIRECTOR 360000 STAFFING AGREEMENT false ADJUVANT PARTNERS LLC FORMER DIRECTOR 897850 REIMBURSEMENT OF EXPENSES false SCHEDULE L, PART IV: (A) NAME OF INTERESTED PERSON: ADJUVANT PARTNERS, LLC (B) RELATIONSHIP BETWEEN INTERESTED PERSON AND THE ORGANIZATION: EDMUND RUFFIN (FORMER DIRECTOR)IS A MANAGING PARTNER OF ADJUVANT PARTNERS, LLC. FORM 990, PART VI, LINE 7A: THE GOVERNING BODY IS ELECTED BY THE MEMBERS AT THE ANNUAL MEETING THAT TAKES PLACE IN THE FALL EACH YEAR. FORM 990, PART VI, LINE 11B: THE TREASURER AND FINANCE COMMITTEE REVIEW THE TAX RETURN. FORM 990, PART VI, LINE 12C: THE CONFLICT OF INTEREST POLICY COVERS ANY DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURE IS TO DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURES ARE REVIEWED AND MAINTAINED BY THE REMAINING MEMBERS OF THE GOVERNING BOARD OR COMMITTEE. THE GOVERNING BOARD OR COMMITTEE REVIEWS EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF POTENTIAL OR ACTUAL CONFLICTS (PAST, PRESENT, OR FUTURE) ARE IDENTIFIED, THE CHAIR PERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGENOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. THE IDENTIFIED CONFLICTS OF INTEREST AND APPROPRIATE RECUSALS ARE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, LINE 19: THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART I, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PARTIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART VI, LINE 3: ADJUVANT PARTNERS, LLC IS ENGAGED TO PROVIDE MANAGEMENT SERVICES FOR ALLIANCE FOR REGENERATIVE MEDICINE.